Ninenovo Blood Oxygen Ring (BORMB-01-6,BORMB-01-7,BORMB-01-8,BORMB-01-9,BORMB-01-10,BORMB-01-11,BORMB-01-12,BORMB-01-13,BORMB-01-14)
Shenzhen Ninenovo Technology Limited · Decision date Oct 2, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on October 2, 2026 for K260490, the Ninenovo Blood Oxygen Ring, submitted by Shenzhen Ninenovo Technology Limited through correspondent Shenzhen Bosstar Consulting Company Limited. The device is a wireless, non-invasive finger-worn pulse oximeter under 21 CFR 870.2700 (Oximeter), Class II, product code DQA, with the Cardiovascular regulation medical specialty and an Anesthesiology review panel. The filing is a Traditional 510(k); clearance is not premarket approval.
The cleared models are BORMB-01-6 through BORMB-01-14, differing by inner diameter (16.5 mm to 23.1 mm) at a stated 7.8 mm width. The summary names the circul pro Ring (K221361) as primary predicate and the Oxiband (Checkme) O2 Pulse Oximeter (K191088) as reference device. Stated indications cover spot-check or continuous SpO2 and pulse rate collection via the index finger in adults, in hospitals and home settings, up to twelve hours in non-motion, well-perfused conditions, without alarms. The summary does not report accuracy results, so comparative performance remains unverified here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 2, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K260490
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Shenzhen Ninenovo Technology Limited
- Product code
- DQA
- Decision code
- SESE
- Decision date
- Oct 2, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Oximeter.
- Applicant
- Shenzhen Ninenovo Technology Limited
- Product code
- DQA
- FDA device class
- 2
FDA decision timeline
K260490 received
Application receipt date recorded by FDA.
K260490 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code DQA
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ANNE LimbK261870 | Sibel Health | 510(k) clearance | Nov 5, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Shenzhen Ninenovo Technology Limited
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Shenzhen
Sources and methodology
- Original FDA record: K260490
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records